Search

everythinglearnresearchcommunity

for

Search:↓

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Stress may affect hair growth by influencing hair follicle development and could contribute to hair loss.

Men have more tryptophan in their hair than women, and it increases with age and is higher in darker and grey or white hair.

Rosemary may help treat various skin conditions due to its antioxidant and anti-inflammatory properties.

Women with pancreatic cancer are more likely to have certain side effects from chemotherapy than men.

Extracellular vesicles show promise for medical use but face challenges in standardization and safety.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

The EQ-5D-5L tool may not accurately measure the impact of alopecia areata on patients' lives.

Patients with alopecia areata on ritlecitinib responded well to tetanus and meningococcal vaccines.

Giant cells found in some male pattern baldness cases may help diagnose it and suggest hair is mistakenly seen as foreign by the body.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

Yale-New Haven Hospital won a top award for greatly improving asthma care and reducing related hospital visits and costs.

Hair loss gene found on chromosome 3q26.

Male pattern baldness involves smaller hair follicles, larger oil glands, and other tissue changes, but not major blood supply issues.

Genetic variation in the androgen receptor gene mainly causes early-onset hair loss, with maternal inheritance playing a key role.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

A portable device can create nanofibers to improve the appearance of thinning hair better than commercial products.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

More severe hair loss in alopecia areata greatly impacts patients and caregivers.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

Hair follicle systems are being engineered to better mimic natural hair follicles for studying hair disorders and testing treatments.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

JAK inhibitors are effective for long-term management of alopecia areata.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.